发明名称 Regulated genetic suicide mechanism compositions and methods
摘要 Embodiments of the present invention relates to the incorporation and use of a regulated genetic suicide mechanism for use in the improved purification of biologics, including adjunct use in various eubacterial minicell production and purification methodologies. Described herein are high-yield eubacterial minicell-producing strains with genetic modifications that comprise a regulated genetic suicide mechanism that irreparably destroys the parent cell chromosome such that live parental cells in a culture can be functionally eliminated at any time during the course of a minicell production and purification run. Embodiments of the present invention also describe methods useful in the elimination of live parental cells during the production of other cell-based biologics.
申请公布号 US9574196(B2) 申请公布日期 2017.02.21
申请号 US201514723775 申请日期 2015.05.28
申请人 Vaxiion Therapeutics, LLC 发明人 Giacalone Matthew J;Maloy Stanley;Tsuji Shingo
分类号 C12N1/20;C12N15/70;C12N1/08;C12N9/22;C12N15/74 主分类号 C12N1/20
代理机构 Knobbe Martens Olson & Bear LLP 代理人 Knobbe Martens Olson & Bear LLP
主权项 1. A eubacterial minicell derived from a minicell-producing bacteria, wherein the minicell-producing bacteria comprises: an expressible cell division gene, wherein the cell division gene is selected from the group consisting of zipA, sulA, secA, dicA, dicB, dicC, dicF, ftsA, ftsI, ftsN, ftsK, ftsL, ftsQ, ftsW, ftsZ, minC, minD, minE, seqA, ccdB, sfiC, and ddlB; and an expressible gene encoding a homing endonuclease, wherein the homing endonuclease gene is a transgene, and wherein the chromosome of the minicell-producing bacteria comprises one or more recognition sites of the homing endonuclease.
地址 San Diego CA US
您可能感兴趣的专利